留言 | Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis | PR Newswire (美通社) | LINE TODAY

您使用的瀏覽器版本較舊，已不再受支援。建議您更新瀏覽器版本，以獲得最佳使用體驗。

請在瀏覽器上啟用JavaScript來瀏覽頁面中的所有內容。

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis

PR Newswire (美通社)

沒有留言。